Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 259103, 10 pages
http://dx.doi.org/10.1093/ecam/nep157
Original Article

Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles

1Department of Cosmetic Applications & Management, Tung Fang Institute of Technology, 829 Kaohsiung County, Taiwan
2School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, 807 Kaohsiung, Taiwan
3Department of Cosmetology and Health Care, Min Hwei College of Health Care Management, 736 Tainan County, Taiwan
4Department of Nursing, Central Taiwan University of Sciences and Technology, 406 Taichung, Taiwan
5Department of Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 1X5
6Department of Microbiology, College of Medicine, Kaohsiung Medical University, 807 Kaohsiung, Taiwan

Received 26 March 2009; Accepted 24 August 2009

Copyright © 2011 Hua-Yew Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Kleymann, R. Fischer, U. A. K. Betz et al., “New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease,” Nature Medicine, vol. 8, no. 4, pp. 392–398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Liuzzi, R. Deziel, N. Moss et al., “A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo,” Nature, vol. 372, no. 6507, pp. 695–698, 1994. View at Google Scholar · View at Scopus
  3. M. W. Wathen, “Non-nucleoside inhibitors of herpesviruses,” Reviews in Medical Virology, vol. 12, no. 3, pp. 167–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. E. de Clercq, “Molecular targets for antiviral agents,” Journal of Pharmacology and Experimental Therapeutics, vol. 297, no. 1, pp. 1–10, 2001. View at Google Scholar · View at Scopus
  5. L. Naesens and E. de Clercq, “Recent developments in herpesvirus therapy,” Herpes, vol. 8, no. 1, pp. 12–16, 2001. View at Google Scholar · View at Scopus
  6. R. Stránská, R. Schuurman, E. Nienhuis et al., “Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization,” Journal of Clinical Virology, vol. 32, no. 1, pp. 7–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ziyaeyan, A. Alborzi, A. Japoni et al., “Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome,” International Journal of Dermatology, vol. 46, pp. 1263–1266, 2007. View at Google Scholar
  8. H. Frangoul, M. Wills, C. Crossno, M. Engel, and J. Domm, “Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution,” Pediatric Transplantation, vol. 11, no. 8, pp. 942–944, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. P. D. Griffiths, “Herpesviruses and AIDS,” Scandinavian Journal of Infectious Diseases, Supplement, vol. 100, supplement, pp. 3–7, 1996. View at Google Scholar · View at Scopus
  10. D. Pillay, D. Mutimer, S. Singhal, A. Turner, K. Ward, and M. Wood, “Management of herpes virus infections following transplantation,” Journal of Antimicrobial Chemotherapy, vol. 45, no. 6, pp. 729–748, 2000. View at Google Scholar · View at Scopus
  11. E. L. Cooper, “Drug discovery, CAM and natural products,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 215–217, 2001. View at Google Scholar · View at Scopus
  12. M. Mukhtar, M. Arshad, M. Ahmad, R. J. Pomerantz, B. Wigdahl, and Z. Parveen, “Antiviral potentials of medicinal plants,” Virus Research, vol. 131, no. 2, pp. 111–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Rajbhandari, R. Mentel, P. K. Jha et al., “Antiviral activity of some plants used in Nepalese traditional medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 4, pp. 517–522, 2009. View at Publisher · View at Google Scholar
  14. M. Saddi, A. Sanna, F. Cottiglia et al., “Antiherpesvirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells,” Annals of Clinical Microbiology and Antimicrobials, vol. 6, p. 10, 2007. View at Google Scholar
  15. L. Chularojmontri, S. K. Wattanapitayakul, A. Herunsalee, S. Charuchongkolwongse, S. Niumsakul, and S. Srichairat, “Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity,” Biological and Pharmaceutical Bulletin, vol. 28, no. 7, pp. 1165–1171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Dias, A. H. Campos, V. Cechinel-Filho, R. A. Yunes, and J. B. Calixto, “Analysis of the mechanisms underlying the contractile responses induced by the hydroalcoholic extract of Phyllanthus urinaria in the guinea pig urinary bladder in-vitro,” Journal of Pharmacy and Pharmacology, vol. 47, pp. 846–851, 1995. View at Google Scholar
  17. S.-H. Fang, Y. K. Rao, and Y.-M. Tzeng, “Anti-oxidant and inflammatory mediator's growth inhibitory effects of compounds isolated from Phyllanthus urinaria,” Journal of Ethnopharmacology, vol. 116, no. 2, pp. 333–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Giridharan, S. T. Somasundaram, K. Perumal et al., “Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis,” British Journal of Cancer, vol. 87, no. 1, pp. 98–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Higashino, A. Suzuki, Y. Tanaka, and K. Pootakham, “Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats,” Nippon Yakurigaku Zasshi, vol. 100, pp. 415–421, 1992. View at Google Scholar
  20. S.-T. Huang, R.-C. Yang, L.-J. Yang, P.-N. Lee, and J.-H. S. Pang, “Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells,” Life Sciences, vol. 72, no. 15, pp. 1705–1716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-T. Huang, R.-C. Yang, M.-Y. Chen, and J.-H. S. Pang, “Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells,” Life Sciences, vol. 75, no. 3, pp. 339–351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-T. Huang, R.-C. Yang, and J.-H. S. Pang, “Aqueous extract of Phyllanthus urinaria induces apoptosis in human cancer cells,” American Journal of Chinese Medicine, vol. 32, no. 2, pp. 175–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-T. Huang, R.-C. Yang, P.-N. Lee et al., “Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma,” International Immunopharmacology, vol. 6, no. 6, pp. 870–879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-H. Lai, S.-H. Fang, Y. K. Rao et al., “Inhibition of Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells by Phyllanthus urinaria extracts,” Journal of Ethnopharmacology, vol. 118, no. 3, pp. 522–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Lans, “Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus,” Journal of Ethnobiology and Ethnomedicine, vol. 2, article 45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Lans, “Comparison of plants used for skin and stomach problems in Trinidad and Tobago with Asian ethnomedicine,” Journal of Ethnobiology and Ethnomedicine, vol. 3, article 3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-Y. Lee, W.-H. Peng, H.-Y. Cheng, F.-N. Chen, M.-T. Lai, and T.-H. Chiu, “Hepatoprotective effect of Phyllanthus in Taiwan on acute liver damage induced by carbon tetrachloride,” American Journal of Chinese Medicine, vol. 34, no. 3, pp. 471–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Y. Lin, C. C. Wang, Y. L. Lu, W. C. Wu, and W. C. Hou, “Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria,” Food and Chemical Toxicology, vol. 46, pp. 2485–2492, 2008. View at Google Scholar
  29. N. Paulino, V. Cechinel-Filho, M. G. Pizzolatti, R. A. Yunes, and J. B. Calixto, “Mechanisms involved in the contractile responses induced by the hydroalcoholic extract of Phyllanthus urinaria on the guinea pig isolated trachea: evidence for participation of tachykinins and influx of extracellular Ca2+ sensitive to ruthenium red,” General Pharmacology, vol. 27, pp. 795–802, 1996. View at Google Scholar
  30. N. Paulino, V. Cechinel-Filho, R. A. Yunes, and J. B. Calixto, “The relaxant effect of extract of Phyllanthus urinaria in the guinea-pig isolated trachea. Evidence for involvement of ATP-sensitive potassium channels,” Journal of Pharmacy and Pharmacology, vol. 48, no. 11, pp. 1158–1163, 1996. View at Google Scholar · View at Scopus
  31. A. R. Santos, V. Cechinel-Filho, R. A. Yunes, and J. B. Calixto, “Analysis of the mechanisms underlying the antinociceptive effect of the extracts of plants from the genus Phyllanthus,” General Pharmacology, vol. 26, pp. 1499–1506, 1995. View at Google Scholar
  32. A. R. S. Santos, R. O. P. de Campos, O. G. Miguel, V. Cechinel-Filho, R. A. Yunes, and J. B. Calixto, “The involvement of K+ channels and G(i/o) protein in the antinociceptive action of the gallic acid ethyl ester,” European Journal of Pharmacology, vol. 379, no. 1, pp. 7–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Shen, J. Yu, S. Wang et al., “Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo,” Hepatology, vol. 47, no. 2, pp. 473–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Xu, Z.-J. Zha, X.-L. Qin, X.-L. Zhang, C.-R. Yang, and Y.-J. Zhang, “Phenolic antioxidants from the whole plant of Phyllanthus urinaria,” Chemistry and Biodiversity, vol. 4, no. 9, pp. 2246–2252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Y. Zhang, D. W. He, G. H. Wei, X. Liu, T. Lin, and X. L. Li, “Phyllanthus urinaria extract promotes N-cadherin expression in nitrogen mustard-disrupted testicular tissues in vivo,” Zhonghua Nan Ke Xue, vol. 14, pp. 396–400, 2008. View at Google Scholar
  36. S. Zhou, C. Xu, N. Zhou et al., “Mechanism of protective action of Phyllanthus urinaria L. against injuries of liver cells,” Zhongguo Zhong Yao Za Zhi, vol. 22, no. 2, pp. 109–111, 1997. View at Google Scholar · View at Scopus
  37. Y. X. Chen, S. H. Guo, and D. F. Zhang, “Experimental study on anti-duck hepatitis B viral effect of Phyllanthus urinaria of different areas and combined therapy with other drugs,” Zhongguo zhong Xi Yi Jie He Za Zhi, vol. 15, no. 4, pp. 225–227, 1995. View at Google Scholar · View at Scopus
  38. X. H. Ji, Y. Z. Qin, W. Y. Wang, J. Y. Zhu, and X. T. Liu, “Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line,” Zhongguo Zhong Yao Za Zhi, vol. 18, no. 8, pp. 496–511, 1993. View at Google Scholar · View at Scopus
  39. M. Wang, H. Cheng, Y. Li, L. Meng, G. Zhao, and K. Mai, “Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites,” Journal of Laboratory and Clinical Medicine, vol. 126, pp. 350–352, 1995. View at Google Scholar
  40. M. X. Wang, H. W. Cheng, Y. J. Li, L. M. Meng, and K. Mai, “Efficacy of Phyllanthus spp. in treating patients with chronic hepatitis B,” Zhongguo Zhong Yao Za Zhi, vol. 19, no. 12, pp. 750–764, 1994. View at Google Scholar · View at Scopus
  41. Y. Zhong, C. Zuo, F. Li et al., “Chemical constituents of Phyllanthus urinaria L. and its antiviral activity against hepatitis B virus,” Zhongguo Zhong Yao Za Zhi, vol. 23, no. 6, pp. 363–384, 1998. View at Google Scholar · View at Scopus
  42. O. Suthienkul, O. Miyazaki, M. Chulasiri, U. Kositanont, and K. Oishi, “Retroviral reverse transcriptase inhibitory activity in Thai herbs and spices: screening with moloney murine leukemia viral enzyme,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 24, no. 4, pp. 751–755, 1993. View at Google Scholar · View at Scopus
  43. K. C. S. C. Liu, M.-T. Lin, S.-S. Lee, J.-F. Chiou, S. Ren, and E. J. Lien, “Antiviral tannins from two Phyllanthus species,” Planta Medica, vol. 65, no. 1, pp. 43–46, 1999. View at Google Scholar · View at Scopus
  44. C.-M. Yang, H.-Y. Cheng, T.-C. Lin, L.-C. Chiang, and C.-C. Lin, “Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro,” Antiviral Research, vol. 67, no. 1, pp. 24–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. C. M. Yang, H. Y. Cheng, T. C. Lin, L. C. Chiang, and C. C. Lin, “The in vitro activity of geraniin and 1, 3, 4, 6-tetra-O-galloyl-β-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection,” Journal of Ethnopharmacology, vol. 110, pp. 555–558, 2007. View at Google Scholar
  46. C.-M. Yang, H.-Y. Cheng, T.-C. Lin, L.-C. Chiang, and C.-C. Lin, “Hippomanin A from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection in vitro,” Phytotherapy Research, vol. 21, no. 12, pp. 1182–1186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. H. Lin, T. Tanaka, G. I. Nonaka, I. Nishioka, and I. S. Chen, “Tannins and related compounds. XCVIII.: structure of three new dimeric ellagitannins, excoecarianin and excoecarinins A and B, isolated from the leaves of Excoecaria kawakamii HAYATA,” Chemical & Pharmaceutical Bulletin, vol. 38, pp. 2162–2171, 1990. View at Google Scholar
  48. F. G. Burleson, T. M. Chambers, and D. L. Wiedbrauk, “Plaque assay,” in Virology: A Laboratory Manual, F. G. Burleson, T. M. Chambers, and D. L. Wiedbrauk, Eds., pp. 74–84, Academic Press, San Diego, Calif, USA, 1992. View at Google Scholar
  49. H.-Y. Cheng, L.-T. Lin, H.-H. Huang, C.-M. Yang, and C.-C. Lin, “Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro,” Antiviral Research, vol. 77, no. 1, pp. 14–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. H.-Y. Cheng, C.-M. Yang, T.-C. Lin, D.-E. Shieh, and C.-C. Lin, “ent-Epiafzelechin-(4α8)-epiafzelechin extracted from Cassia javanica inhibits herpes simplex virus type 2 replication,” Journal of Medical Microbiology, vol. 55, no. 2, pp. 201–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. H.-Y. Cheng, T.-C. Lin, C.-M. Yang, K.-C. Wang, L.-T. Lin, and C.-C. Lin, “Putranjivain A from Euphorbia jolkini inhibits both virus entry and late stage replication of herpes simplex virus type 2 in vitro,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 4, pp. 577–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Lawetz and M. Liuzzi, “The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture,” Antiviral Research, vol. 39, no. 1, pp. 35–46, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Piret, S. Roy, M. Gagnon et al., “Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 9, pp. 2933–2942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Suhnel, “Evaluation of synergism or antagonism for the combined action of antiviral agents,” Antiviral Research, vol. 13, no. 1, pp. 23–40, 1990. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Roizman and P. E. Pellet, “The family Herpesviridae: a brief introduction,” in Fields’ Virology, D. M. Knipe, P. M. Howley, and D. E. Griffin, Eds., pp. 2381–2397, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 2001. View at Google Scholar
  56. S. I. Gerber, B. J. Belval, and B. C. Herold, “Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism,” Virology, vol. 214, pp. 29–39, 1995. View at Google Scholar
  57. A. H. Rux, H. Lou, J. D. Lambris, H. M. Friedman, R. J. Eisenberg, and G. H. Cohen, “Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b,” Virology, vol. 294, no. 2, pp. 324–332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Danve-Szatanek, M. Aymard, D. Thouvenot et al., “Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up,” Journal of Clinical Microbiology, vol. 42, no. 1, pp. 242–249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. K. A. Cassady and R. J. Whitley, “New therapeutic approaches to the alphaherpesvirus infections,” Journal of Antimicrobial Chemotherapy, vol. 39, no. 2, pp. 119–128, 1997. View at Publisher · View at Google Scholar · View at Scopus